{
  "type": "hyp",
  "text": "We observed in the present study that lysoPC (1 to 10 micromol/L) dose-dependently inhibited TF activity in human monocytes as elicited by lipopolysaccharide (LPS).\n",
  "self": {
    "NER": {
      "answers": [
        "lysoPC",
        "1",
        "10",
        "TF",
        "LPS"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What inhibited TF activity in human monocytes?",
          "What is the dose-dependent inhibition of TF activity?",
          "What is the dose of lysoPC?",
          "What activity was inhibited by lysoPC?",
          "What is the name of the substance that elicits TF activity?"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "We",
        "the present study",
        "lysoPC",
        "(1 to 10 micromol/L",
        "dose",
        "TF activity",
        "human monocytes",
        "lipopolysaccharide",
        "(LPS"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What did the present study find about lysoPC?",
          "What study did we observe that lysoPC inhibited TF activity in human",
          "What inhibited TF activity in human monocytes?",
          "What dose-dependent inhibitor inhibited TF activity in human monocytes?",
          "What was the main factor that triggered TF activity?",
          "What did lysoPC inhibit in human monocytes?",
          "What did lysoPC inhibit TF activity in?",
          "What is the name of the substance that elicits TF activity?",
          "What is the name of the lipopolysaccharide?"
        ]
      }
    }
  },
  "asked": {
    "What drug reduced TF activity in human monocytes?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "lysoPC",
        "answerability": 0.9062584638595581,
        "ground_truth": {
          "lysoPC": {
            "bertscore": 1.0,
            "f1": 1.0
          }
        }
      }
    },
    "What is the dose-dependent effect of lysoPC on TF activity?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "inhibited",
        "answerability": 0.9996610283851624,
        "ground_truth": {
          "1": {
            "bertscore": 0.7114648222923279,
            "f1": 0
          }
        }
      }
    },
    "What is the dose of lysoPC?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "1 to 10 micromol/L",
        "answerability": 0.8108888864517212,
        "ground_truth": {
          "10": {
            "bertscore": 0.5923559069633484,
            "f1": 0.4
          }
        }
      }
    },
    "What activity was reduced by lysoPC?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "TF",
        "answerability": 0.9717156291007996,
        "ground_truth": {
          "TF": {
            "bertscore": 1.0,
            "f1": 1.0
          }
        }
      }
    },
    "What is the name of the substance that causes TF activity to decrease?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.28962212800979614,
        "ground_truth": {
          "LPS": {
            "bertscore": 0.7027957439422607,
            "f1": 0
          }
        }
      }
    },
    "What did the present study show about lysoPC?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "dose-dependently inhibited TF activity",
        "answerability": 0.9963732957839966,
        "ground_truth": {
          "We": {
            "bertscore": 0.5725670456886292,
            "f1": 0
          }
        }
      }
    },
    "What study showed that lysoPC reduced TF activity in human monocytes?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.11575430631637573,
        "ground_truth": {
          "the present study": {
            "bertscore": 0.6727140545845032,
            "f1": 0
          }
        }
      }
    },
    "What dose-dependently reduced TF activity in human monocytes?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.34227466583251953,
        "ground_truth": {
          "(1 to 10 micromol/L": {
            "bertscore": 0.5709236860275269,
            "f1": 0
          }
        }
      }
    },
    "What was the main factor that elicited TF activity?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "lipopolysaccharide",
        "answerability": 0.5297067165374756,
        "ground_truth": {
          "dose": {
            "bertscore": 0.5642301440238953,
            "f1": 0
          }
        }
      }
    },
    "What did lysoPC reduce in human monocytes?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "TF activity",
        "answerability": 0.6956648826599121,
        "ground_truth": {
          "TF activity": {
            "bertscore": 1.0,
            "f1": 1.0
          }
        }
      }
    },
    "What did lysoPC reduce TF activity in?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "human monocytes",
        "answerability": 0.6417551040649414,
        "ground_truth": {
          "human monocytes": {
            "bertscore": 0.9999998807907104,
            "f1": 1.0
          }
        }
      }
    },
    "What is the name of the substance that causes TF activity to be reduced?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.3850577473640442,
        "ground_truth": {
          "lipopolysaccharide": {
            "bertscore": 0.5850990414619446,
            "f1": 0
          }
        }
      }
    },
    "What is the name of the lipopolysaccharide?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.01716327667236328,
        "ground_truth": {
          "(LPS": {
            "bertscore": 0.6541221737861633,
            "f1": 0
          }
        }
      }
    }
  }
}